Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaagliptin cardiovascular outcomes in type 2 diabetes (China cohort of CARMELINA)
CTR20150659Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Boehringer Ingelheim. Started Oct 2015; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20150659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150659.